1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    June 2-3

Programme

Indicated times are in CEST timezone.

16:00

Start of sessions

Session 1
Session 1
16:00
Opening & introduction
Dr Jean-Yves ORTHOLAND
EDELRIS, Lyon, France
Dr Allen ANNIS
AILERON THERAPEUTICS, Cambridge, United States
16:10
Targeting RNA With Small Molecules Using Affinity-Selection Mass Spectrometry (KL01)
Dr Elliot B. NICKBARG
MERCK RESEARCH LABORATORIES, Boston, United States
16:55
Discovery of Bioactive Natural Products Using Affinity Selection-Mass Spectrometry (PL01)
Prof. Richard VAN BREEMEN
OREGON STATE UNIVERSITY, Corvallis, United States
17:30
Short break
17:40
Accelerating Drug Discovery with the Integration of Affinity Selection Mass Spectrometry (PL02)
Dr Damian HOUDE
RELAY THERAPEUTICS, Cambridge, United States
18:15
Fishing from an Exclusive Pond Using AS-MS (PL03)
Dr Didier ROCHE
EDELRIS, Lyon, France
18:30
Closing remarks Day 1
16:00

Start of sessions

Session 2
Session 2
16:00
Opening remarks
Dr Didier ROCHE
EDELRIS, Lyon, France
16:05
Adapting the AS-MS Technology to GPCR Ligand Discovery (PL04)
Prof. Wenqing SHUI
SHANGHAITECH UNIVERSITY, Shanghai, China
16:40
Lessons Learned from Pfizer’s Experience in utilizing Affinity Selection by Mass Spectrometry for Hit Identification (PL05)
Dr Matthew D. TROUTMAN
PFIZER, Groton, United States
17:15
Short break
17:25
MALDI-TOF AS-MS – a Viable Alternative for LC-MS-based Workflows? (PL06)
Dr Roman SIMON
BOEHRINGER INGELHEIM PHARMA, Biberach, Germany
18:00
Closing remarks & end of the conference